Skip to main content
. Author manuscript; available in PMC: 2013 May 14.
Published in final edited form as: Arthritis Rheum. 2008 Aug 15;59(8):1082–1089. doi: 10.1002/art.23923

Table 3.

Prediction of work disability by use of anti-TNF agents*

Work disability outcome Anti-TNF use No. of cases No. of controls Crude OR Adjusted OR (95% CI)†
Any employment loss Yes 106 351 0.8 1.1 (0.7–1.6)
No 125 371 1.0 1.0 (reference)
RA-attributable employment loss Yes 61 300 0.9 (0.5–1.5)
No 63 296 1.0 (reference)
*

Anti-TNF = anti–tumor necrosis factor; OR = odds ratio; 95% CI = 95% confidence interval; RA = rheumatoid arthritis.

†

Adjusted for age, sex, education, personal income, RA duration, functional limitation, RA global severity, hours worked per week, type of job, self-employment, stressful job, and work preference.